Elisabetta Perrone

10PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPharmaceutical delivery technologiesSolid tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 03, 2026
Recurrent Metastatic Esthesioneuroblastoma: First-in-human α/β PRRT With Actinium-225/Lutetium-177-DOTA-LM3 SSTR Antagonist Achieving Partial Response After Failure of Lutetium-177-DOTATOC PRRT.

|Apr 01, 2026
First-in-Human Combination of Lead-212-Labeled PSMA Radioligand Therapy and Metabotropic Glutamate Receptor Inhibitor Riluzole as Radiosensitizer in Metastatic Castration-resistant Prostate Cancer.

Elisabetta Perrone, Lukas Greifenstein, Kriti Ghai

|Nov 27, 2025
First Autopsy-confirmed Complete Remission of Metastatic Neuroendocrine Neoplasm of Tailgut Cyst After a Single Cycle of Alpha-Peptide Receptor Radionuclide Therapy With [ 225 Ac]Ac-DOTA-LM3.

Elisabetta Perrone, Shagufta Shaheen, Pamela L Kunz

|Sep 27, 2025
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival.

Elisabetta Perrone, Maria Lucia Calcagni, Lucia Leccisotti

|Jul 29, 2025
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies.

Elisabetta Perrone, Giorgio Treglia, Romina Grazia Giancipoli

|Mar 07, 2025
TANDEM Peptide Receptor Radionuclide Therapy Using [ 225 Ac]Ac-/[ 177 Lu]Lu-DOTA-LM3 in a Patient With Parotid Gland Metastasis From Pancreatic Neuroendocrine Neoplasm.

Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant

Pageof 2

Frequent Collaborators

4 joint publications

Richard Paul Baum

3 joint publications

Aleksandr Eismant

3 joint publications

Lucia Leccisotti

3 joint publications

Tanay Parkar